Remicade (infliximab) Drug Market - Global Outlook and Forecast 2021-2027

Code: RW00014630259
Market Monitor Global
Nov-2021
Life Sciences
92 Pages

This report contains market size and forecasts of Remicade (infliximab) Drug in global, including the following market information:
Global Remicade (infliximab) Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Remicade (infliximab) Drug Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Remicade (infliximab) Drug companies in 2020 (%)
The global Remicade (infliximab) Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Remicade (infliximab) Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Remicade (infliximab) Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Remicade (infliximab) Drug Market Segment Percentages, By Type, 2020 (%)
Brands Drugs
Generic Drugs

Global Remicade (infliximab) Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Remicade (infliximab) Drug Market Segment Percentages, By Application, 2020 (%)
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Pediatric Ulcerative Colitis
Other

Global Remicade (infliximab) Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Remicade (infliximab) Drug Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Remicade (infliximab) Drug revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Remicade (infliximab) Drug revenues share in global market, 2020 (%)
Key companies Remicade (infliximab) Drug sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Remicade (infliximab) Drug sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Janssen
Hospira
Celltrion Healthcare
Epirus Biopharmaceuticals
Samsung Bioepsis

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Remicade (infliximab) Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Remicade (infliximab) Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Remicade (infliximab) Drug Overall Market Size
2.1 Global Remicade (infliximab) Drug Market Size: 2021 VS 2027
2.2 Global Remicade (infliximab) Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Remicade (infliximab) Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Remicade (infliximab) Drug Players in Global Market
3.2 Top Global Remicade (infliximab) Drug Companies Ranked by Revenue
3.3 Global Remicade (infliximab) Drug Revenue by Companies
3.4 Global Remicade (infliximab) Drug Sales by Companies
3.5 Global Remicade (infliximab) Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Remicade (infliximab) Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Remicade (infliximab) Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Remicade (infliximab) Drug Players in Global Market
3.8.1 List of Global Tier 1 Remicade (infliximab) Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Remicade (infliximab) Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Remicade (infliximab) Drug Market Size Markets, 2021 & 2027
4.1.2 Brands Drugs
4.1.3 Generic Drugs
4.2 By Type - Global Remicade (infliximab) Drug Revenue & Forecasts
4.2.1 By Type - Global Remicade (infliximab) Drug Revenue, 2016-2021
4.2.2 By Type - Global Remicade (infliximab) Drug Revenue, 2022-2027
4.2.3 By Type - Global Remicade (infliximab) Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Remicade (infliximab) Drug Sales & Forecasts
4.3.1 By Type - Global Remicade (infliximab) Drug Sales, 2016-2021
4.3.2 By Type - Global Remicade (infliximab) Drug Sales, 2022-2027
4.3.3 By Type - Global Remicade (infliximab) Drug Sales Market Share, 2016-2027
4.4 By Type - Global Remicade (infliximab) Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Remicade (infliximab) Drug Market Size, 2021 & 2027
5.1.2 Crohn's Disease
5.1.3 Pediatric Crohn's Disease
5.1.4 Ulcerative Colitis
5.1.5 Pediatric Ulcerative Colitis
5.1.6 Other
5.2 By Application - Global Remicade (infliximab) Drug Revenue & Forecasts
5.2.1 By Application - Global Remicade (infliximab) Drug Revenue, 2016-2021
5.2.2 By Application - Global Remicade (infliximab) Drug Revenue, 2022-2027
5.2.3 By Application - Global Remicade (infliximab) Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Remicade (infliximab) Drug Sales & Forecasts
5.3.1 By Application - Global Remicade (infliximab) Drug Sales, 2016-2021
5.3.2 By Application - Global Remicade (infliximab) Drug Sales, 2022-2027
5.3.3 By Application - Global Remicade (infliximab) Drug Sales Market Share, 2016-2027
5.4 By Application - Global Remicade (infliximab) Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Remicade (infliximab) Drug Market Size, 2021 & 2027
6.2 By Region - Global Remicade (infliximab) Drug Revenue & Forecasts
6.2.1 By Region - Global Remicade (infliximab) Drug Revenue, 2016-2021
6.2.2 By Region - Global Remicade (infliximab) Drug Revenue, 2022-2027
6.2.3 By Region - Global Remicade (infliximab) Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Remicade (infliximab) Drug Sales & Forecasts
6.3.1 By Region - Global Remicade (infliximab) Drug Sales, 2016-2021
6.3.2 By Region - Global Remicade (infliximab) Drug Sales, 2022-2027
6.3.3 By Region - Global Remicade (infliximab) Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Remicade (infliximab) Drug Revenue, 2016-2027
6.4.2 By Country - North America Remicade (infliximab) Drug Sales, 2016-2027
6.4.3 US Remicade (infliximab) Drug Market Size, 2016-2027
6.4.4 Canada Remicade (infliximab) Drug Market Size, 2016-2027
6.4.5 Mexico Remicade (infliximab) Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Remicade (infliximab) Drug Revenue, 2016-2027
6.5.2 By Country - Europe Remicade (infliximab) Drug Sales, 2016-2027
6.5.3 Germany Remicade (infliximab) Drug Market Size, 2016-2027
6.5.4 France Remicade (infliximab) Drug Market Size, 2016-2027
6.5.5 U.K. Remicade (infliximab) Drug Market Size, 2016-2027
6.5.6 Italy Remicade (infliximab) Drug Market Size, 2016-2027
6.5.7 Russia Remicade (infliximab) Drug Market Size, 2016-2027
6.5.8 Nordic Countries Remicade (infliximab) Drug Market Size, 2016-2027
6.5.9 Benelux Remicade (infliximab) Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Remicade (infliximab) Drug Revenue, 2016-2027
6.6.2 By Region - Asia Remicade (infliximab) Drug Sales, 2016-2027
6.6.3 China Remicade (infliximab) Drug Market Size, 2016-2027
6.6.4 Japan Remicade (infliximab) Drug Market Size, 2016-2027
6.6.5 South Korea Remicade (infliximab) Drug Market Size, 2016-2027
6.6.6 Southeast Asia Remicade (infliximab) Drug Market Size, 2016-2027
6.6.7 India Remicade (infliximab) Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Remicade (infliximab) Drug Revenue, 2016-2027
6.7.2 By Country - South America Remicade (infliximab) Drug Sales, 2016-2027
6.7.3 Brazil Remicade (infliximab) Drug Market Size, 2016-2027
6.7.4 Argentina Remicade (infliximab) Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Remicade (infliximab) Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Remicade (infliximab) Drug Sales, 2016-2027
6.8.3 Turkey Remicade (infliximab) Drug Market Size, 2016-2027
6.8.4 Israel Remicade (infliximab) Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Remicade (infliximab) Drug Market Size, 2016-2027
6.8.6 UAE Remicade (infliximab) Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Janssen
7.1.1 Janssen Corporate Summary
7.1.2 Janssen Business Overview
7.1.3 Janssen Remicade (infliximab) Drug Major Product Offerings
7.1.4 Janssen Remicade (infliximab) Drug Sales and Revenue in Global (2016-2021)
7.1.5 Janssen Key News
7.2 Hospira
7.2.1 Hospira Corporate Summary
7.2.2 Hospira Business Overview
7.2.3 Hospira Remicade (infliximab) Drug Major Product Offerings
7.2.4 Hospira Remicade (infliximab) Drug Sales and Revenue in Global (2016-2021)
7.2.5 Hospira Key News
7.3 Celltrion Healthcare
7.3.1 Celltrion Healthcare Corporate Summary
7.3.2 Celltrion Healthcare Business Overview
7.3.3 Celltrion Healthcare Remicade (infliximab) Drug Major Product Offerings
7.3.4 Celltrion Healthcare Remicade (infliximab) Drug Sales and Revenue in Global (2016-2021)
7.3.5 Celltrion Healthcare Key News
7.4 Epirus Biopharmaceuticals
7.4.1 Epirus Biopharmaceuticals Corporate Summary
7.4.2 Epirus Biopharmaceuticals Business Overview
7.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Major Product Offerings
7.4.4 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales and Revenue in Global (2016-2021)
7.4.5 Epirus Biopharmaceuticals Key News
7.5 Samsung Bioepsis
7.5.1 Samsung Bioepsis Corporate Summary
7.5.2 Samsung Bioepsis Business Overview
7.5.3 Samsung Bioepsis Remicade (infliximab) Drug Major Product Offerings
7.5.4 Samsung Bioepsis Remicade (infliximab) Drug Sales and Revenue in Global (2016-2021)
7.5.5 Samsung Bioepsis Key News
8 Global Remicade (infliximab) Drug Production Capacity, Analysis
8.1 Global Remicade (infliximab) Drug Production Capacity, 2016-2027
8.2 Remicade (infliximab) Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Remicade (infliximab) Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Remicade (infliximab) Drug Supply Chain Analysis
10.1 Remicade (infliximab) Drug Industry Value Chain
10.2 Remicade (infliximab) Drug Upstream Market
10.3 Remicade (infliximab) Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Remicade (infliximab) Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Remicade (infliximab) Drug in Global Market
Table 2. Top Remicade (infliximab) Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Remicade (infliximab) Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Remicade (infliximab) Drug Revenue Share by Companies, 2016-2021
Table 5. Global Remicade (infliximab) Drug Sales by Companies, (K Units), 2016-2021
Table 6. Global Remicade (infliximab) Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Remicade (infliximab) Drug Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Remicade (infliximab) Drug Product Type
Table 9. List of Global Tier 1 Remicade (infliximab) Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Remicade (infliximab) Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Remicade (infliximab) Drug Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Remicade (infliximab) Drug Sales (K Units), 2016-2021
Table 15. By Type - Global Remicade (infliximab) Drug Sales (K Units), 2022-2027
Table 16. By Application - Global Remicade (infliximab) Drug Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Remicade (infliximab) Drug Sales (K Units), 2016-2021
Table 20. By Application - Global Remicade (infliximab) Drug Sales (K Units), 2022-2027
Table 21. By Region - Global Remicade (infliximab) Drug Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Remicade (infliximab) Drug Sales (K Units), 2016-2021
Table 25. By Region - Global Remicade (infliximab) Drug Sales (K Units), 2022-2027
Table 26. By Country - North America Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Remicade (infliximab) Drug Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Remicade (infliximab) Drug Sales, (K Units), 2016-2021
Table 29. By Country - North America Remicade (infliximab) Drug Sales, (K Units), 2022-2027
Table 30. By Country - Europe Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Remicade (infliximab) Drug Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Remicade (infliximab) Drug Sales, (K Units), 2016-2021
Table 33. By Country - Europe Remicade (infliximab) Drug Sales, (K Units), 2022-2027
Table 34. By Region - Asia Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Remicade (infliximab) Drug Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Remicade (infliximab) Drug Sales, (K Units), 2016-2021
Table 37. By Region - Asia Remicade (infliximab) Drug Sales, (K Units), 2022-2027
Table 38. By Country - South America Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Remicade (infliximab) Drug Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Remicade (infliximab) Drug Sales, (K Units), 2016-2021
Table 41. By Country - South America Remicade (infliximab) Drug Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Remicade (infliximab) Drug Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Remicade (infliximab) Drug Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Remicade (infliximab) Drug Sales, (K Units), 2022-2027
Table 46. Janssen Corporate Summary
Table 47. Janssen Remicade (infliximab) Drug Product Offerings
Table 48. Janssen Remicade (infliximab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Hospira Corporate Summary
Table 50. Hospira Remicade (infliximab) Drug Product Offerings
Table 51. Hospira Remicade (infliximab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Celltrion Healthcare Corporate Summary
Table 53. Celltrion Healthcare Remicade (infliximab) Drug Product Offerings
Table 54. Celltrion Healthcare Remicade (infliximab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Epirus Biopharmaceuticals Corporate Summary
Table 56. Epirus Biopharmaceuticals Remicade (infliximab) Drug Product Offerings
Table 57. Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Samsung Bioepsis Corporate Summary
Table 59. Samsung Bioepsis Remicade (infliximab) Drug Product Offerings
Table 60. Samsung Bioepsis Remicade (infliximab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Remicade (infliximab) Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 62. Global Remicade (infliximab) Drug Capacity Market Share of Key Manufacturers, 2019-2021
Table 63. Global Remicade (infliximab) Drug Production by Region, 2016-2021 (K Units)
Table 64. Global Remicade (infliximab) Drug Production by Region, 2022-2027 (K Units)
Table 65. Remicade (infliximab) Drug Market Opportunities & Trends in Global Market
Table 66. Remicade (infliximab) Drug Market Drivers in Global Market
Table 67. Remicade (infliximab) Drug Market Restraints in Global Market
Table 68. Remicade (infliximab) Drug Raw Materials
Table 69. Remicade (infliximab) Drug Raw Materials Suppliers in Global Market
Table 70. Typical Remicade (infliximab) Drug Downstream
Table 71. Remicade (infliximab) Drug Downstream Clients in Global Market
Table 72. Remicade (infliximab) Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Remicade (infliximab) Drug Segment by Type
Figure 2. Remicade (infliximab) Drug Segment by Application
Figure 3. Global Remicade (infliximab) Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Remicade (infliximab) Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Remicade (infliximab) Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. Remicade (infliximab) Drug Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Remicade (infliximab) Drug Revenue in 2020
Figure 9. By Type - Global Remicade (infliximab) Drug Sales Market Share, 2016-2027
Figure 10. By Type - Global Remicade (infliximab) Drug Revenue Market Share, 2016-2027
Figure 11. By Type - Global Remicade (infliximab) Drug Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Remicade (infliximab) Drug Sales Market Share, 2016-2027
Figure 13. By Application - Global Remicade (infliximab) Drug Revenue Market Share, 2016-2027
Figure 14. By Application - Global Remicade (infliximab) Drug Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Remicade (infliximab) Drug Sales Market Share, 2016-2027
Figure 16. By Region - Global Remicade (infliximab) Drug Revenue Market Share, 2016-2027
Figure 17. By Country - North America Remicade (infliximab) Drug Revenue Market Share, 2016-2027
Figure 18. By Country - North America Remicade (infliximab) Drug Sales Market Share, 2016-2027
Figure 19. US Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Remicade (infliximab) Drug Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Remicade (infliximab) Drug Sales Market Share, 2016-2027
Figure 24. Germany Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 25. France Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Remicade (infliximab) Drug Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Remicade (infliximab) Drug Sales Market Share, 2016-2027
Figure 33. China Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 37. India Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Remicade (infliximab) Drug Revenue Market Share, 2016-2027
Figure 39. By Country - South America Remicade (infliximab) Drug Sales Market Share, 2016-2027
Figure 40. Brazil Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Remicade (infliximab) Drug Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Remicade (infliximab) Drug Sales Market Share, 2016-2027
Figure 44. Turkey Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Remicade (infliximab) Drug Revenue, (US$, Mn), 2016-2027
Figure 48. Global Remicade (infliximab) Drug Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Remicade (infliximab) Drug by Region, 2020 VS 2027
Figure 50. Remicade (infliximab) Drug Industry Value Chain
Figure 51. Marketing Channels

Janssen
Hospira
Celltrion Healthcare
Epirus Biopharmaceuticals
Samsung Bioepsis

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE